ARCT - Why Arcturus Therapeutics Stock Soared Today
Shares of Arcturus Therapeutics Holdings (NASDAQ: ARCT) were soaring 12.7% higher as of 3:28 p.m. EST on Tuesday. The big jump came after the clinical-stage biotech provided its third-quarter update following the market close on Monday. Investors were less interested in Arcturus' financial results than they were in the company's encouraging interim phase 1/2 results for its coronavirus vaccine candidate ARCT-021.
There's no question that ARCT-021 looked promising based on the company's interim phase 1/2 results. What's especially attractive is that it could be effective at low doses.
Image source: Getty Images.
For further details see:
Why Arcturus Therapeutics Stock Soared Today